Back
Open Access

Assessing risk and optimizing outcomes – What do the data tell us?

Session: Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2
Topic: Treatment
Speaker: Professor V. McLaughlin (Ann Arbor, US)
Sponsored by Actelion Pharmaceuticals Ltd
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)
5 presentations
0 follower

4 more presentations in this session

Introduction - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2

Speaker: Professor A. Torbicki (Otwock, PL)

Access
Slides
Video
Thumbnail

From risk assessment to treatment strategy – A patient case.

Speaker: Doctor F. Bauer (Rouen, FR)

Access
Slides
Video
Thumbnail

Panel discussion - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Speaker: Professor S. Rosenkranz (Cologne, DE) Professor A. Torbicki (Otwock, PL) Professor V. McLaughlin (Ann Arbor, US) Doctor F. Bauer (Rouen, FR)

Access
Video
Thumbnail

Closing remarks - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Speaker: Professor S. Rosenkranz (Cologne, DE)

Access
Slides
Video
Thumbnail

Access the full session

Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2

Speakers: Professor V. McLaughlin, Professor A. Torbicki, Doctor F. Bauer, Professor S. Rosenkranz, Professor A. Torbicki...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb